Ranked #1,433 of 8,699 institutional investors
Braidwell LP
Stamford, CT
$2.18B
US stock portfolio at live prices · today −$27.8M (−1.26%)
Market closed. Prices as of Nov 20, 5:41 AM ET
- Value at quarter end (Q3 2026)
- $2.32B
- Change from Q2 2026
- −$280.7M (−10.78%)
- Positions
- 74 · 12 new, 9 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: $86.3M of convertible notes and other principal-amount securities. $146M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesKOD 4.88%EWTX 3.91%GKOS 3.76%HNGE 3.25%SYRE 3.20%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| KOD Kodiak Sciences Inc. | 1,085,743 | $106M | 4.88% | Reduced −39% |
| EWTX Edgewise Therapeutics, Inc. | 2,069,091 | $85.2M | 3.91% | Added +4% |
| GKOS Glaukos Corporation | 343,873 | $81.9M | 3.76% | Reduced −42% |
| HNGE Hinge Health, Inc. | 655,306 | $70.8M | 3.25% | Reduced −51% |
| SYRE Spyre Therapeutics, Inc. | 713,957 | $69.7M | 3.20% | Reduced −19% |
| XENE Xenon Pharmaceuticals Inc. | 1,708,435 | $64.2M | 2.95% | Added +51% |
| TMDX TransMedics Group, Inc. | 654,178 | $61.5M | 2.83% | Added +7% |
| IRTC iRhythm Holdings, Inc. | 640,562 | $60.4M | 2.77% | Reduced −2% |
| NBIX Neurocrine Biosciences, Inc. | 336,571 | $52.7M | 2.42% | Added +0% |
| BTSG BrightSpring Health Services, Inc. | 802,472 | $51.4M | 2.36% | Added +34% |
| ISRG Intuitive Surgical, Inc. | 125,957 | $51.3M | 2.36% | Added +80% |
| CAI Caris Life Sciences, Inc. | 2,746,688 | $50.9M | 2.34% | Reduced −67% |
| NEO NeoGenomics, Inc. | 3,348,502 | $50.5M | 2.32% | Reduced −32% |
| ATEC Alphatec Holdings, Inc. | 7,228,839 | $49.9M | 2.29% | Added +11% |
| ACHC Acadia Healthcare Company, Inc. | 1,352,693 | $46.6M | 2.14% | Added +19% |
| VERA Vera Therapeutics, Inc. | 1,726,693 | $46.2M | 2.12% | Added +206% |
| DNTH Dianthus Therapeutics, Inc. | 518,398 | $44.0M | 2.02% | Reduced −13% |
| AVAH Aveanna Healthcare Holdings Inc. | 3,870,106 | $41.4M | 1.90% | Added +26% |
| MRVI Maravai LifeSciences Holdings, Inc. | 5,503,086 | $39.6M | 1.82% | Reduced −37% |
| MAZE Maze Therapeutics, Inc. | 1,149,735 | $37.3M | 1.71% | Added +1% |
| KRYS Krystal Biotech, Inc. | 114,077 | $36.0M | 1.66% | Reduced −12% |
| KYMR Kymera Therapeutics, Inc. | 300,569 | $35.9M | 1.65% | Reduced −21% |
| KIDS OrthoPediatrics Corp. | 1,100,370 | $35.8M | 1.64% | Unchanged |
| DHR Danaher Corporation | 141,504 | $32.2M | 1.48% | Reduced −6% |
| NVCT Nuvectis Pharma, Inc. | 1,573,823 | $31.2M | 1.43% | New |
| ORKA Oruka Therapeutics, Inc. | 319,679 | $31.2M | 1.43% | Added +15% |
| ALMR Alamar Biosciences, Inc. | 1,083,983 | $31.1M | 1.43% | Unchanged |
| HUM Humana Inc. | 81,399 | $30.9M | 1.42% | Reduced −29% |
| GENB Generate Biomedicines, Inc. | 2,962,249 | $30.7M | 1.41% | Reduced −10% |
| RYTM Rhythm Pharmaceuticals, Inc. | 255,828 | $29.9M | 1.37% | Reduced −33% |
| TMO Thermo Fisher Scientific Inc. | 41,675 | $28.7M | 1.32% | Reduced −53% |
| CLYM Climb Bio Inc | 2,863,350 | $26.6M | 1.22% | Added +2% |
| INSP Inspire Medical Systems, Inc. | 464,470 | $26.1M | 1.20% | Reduced −31% |
| BSX Boston Scientific Corporation | 587,567 | $25.3M | 1.16% | Unchanged |
| IMCR Immunocore Holdings plc | 906,115 | $24.1M | 1.11% | Added +74% |
| GLUE Monte Rosa Therapeutics, Inc. | 2,526,009 | $22.5M | 1.03% | Added +3% |
| EOLS Evolus, Inc. | 3,084,022 | $21.6M | 0.99% | Reduced −2% |
| AVLN Avalyn Pharma Inc. | 744,460 | $21.4M | 0.98% | Reduced −7% |
| MBX MBX Biosciences, Inc. | 398,951 | $21.3M | 0.98% | Reduced −44% |
| CRVS Corvus Pharmaceuticals, Inc. | 1,931,402 | $19.3M | 0.89% | Reduced −9% |
| RGEN Repligen Corporation | 111,500 | $19.0M | 0.87% | Reduced −37% |
| NTRA Natera, Inc. | 59,900 | $17.4M | 0.80% | Reduced −25% |
| GH Guardant Health, Inc. | 117,910 | $17.2M | 0.79% | Reduced −20% |
| CSTL Castle Biosciences, Inc. | 502,508 | $16.8M | 0.77% | New |
| SYK Stryker Corporation | 49,560 | $15.5M | 0.71% | New |
| OVID Ovid Therapeutics Inc. | 6,582,421 | $15.4M | 0.71% | Added +11% |
| NKTR Nektar Therapeutics | 443,591 | $14.4M | 0.66% | Reduced −6% |
| LFST LifeStance Health Group, Inc. | 975,385 | $13.0M | 0.60% | New |
| SEPN Septerna, Inc. | 328,240 | $12.9M | 0.59% | New |
| NRIX Nurix Therapeutics, Inc. | 871,104 | $11.8M | 0.54% | Reduced −32% |
| COGT Cogent Biosciences, Inc. | 400,913 | $11.1M | 0.51% | New |
| AVTX Avalo Therapeutics, Inc. | 1,609,392 | $10.9M | 0.50% | Reduced −1% |
| DGX Quest Diagnostics Incorporated | 40,400 | $10.5M | 0.48% | Reduced −6% |
| SRZN Surrozen, Inc. | 335,206 | $10.3M | 0.47% | Reduced −14% |
| DRUG Bright Minds Biosciences Inc. | 483,822 | $10.0M | 0.46% | Unchanged |
| SPTX Seaport Therapeutics, Inc. | 481,489 | $8.8M | 0.41% | Reduced −4% |
| ETRA Electra Therapeutics, Inc. | 905,731 | $8.1M | 0.37% | New |
| TECX Tectonic Therapeutic, Inc. | 371,102 | $7.8M | 0.36% | Reduced −38% |
| ORIC ORIC Pharmaceuticals, Inc. | 990,959 | $7.6M | 0.35% | Reduced −18% |
| ELV Elevance Health, Inc. | 19,440 | $7.6M | 0.35% | Reduced −64% |
| ANL Adlai Nortye Group Ltd. | 795,214 | $7.2M | 0.33% | Unchanged |
| XFOR X4 Pharmaceuticals, Inc. | 2,344,822 | $6.9M | 0.32% | Reduced −20% |
| ACRS Aclaris Therapeutics, Inc. | 1,753,978 | $6.1M | 0.28% | Reduced −18% |
| VOR Vor Biopharma Inc. | 319,308 | $5.9M | 0.27% | Reduced −44% |
| BIOA BioAge Labs, Inc. | 1,033,129 | $4.9M | 0.22% | Unchanged |
| IONS Ionis Pharmaceuticals, Inc. | 176,462 | $4.8M | 0.22% | Added +51% |
| IMUX Immunic, Inc. | 645,110 | $4.8M | 0.22% | Unchanged |
| YARW Yarrow Bioscience, Inc. | 331,400 | $4.7M | 0.22% | New |
| ADRX ADARx Pharmaceuticals, Inc. | 300,000 | $4.2M | 0.20% | New |
| ATTO Attovia Therapeutics, Inc. | 225,000 | $3.5M | 0.16% | New |
| CGON CG Oncology, Inc. | 41,100 | $3.4M | 0.15% | New |
| LUNG Pulmonx Corporation | 752,541 | $2.1M | <0.1% | Unchanged |
| KRSA Korsana Biosciences, Inc. | 43,042 | $1.5M | <0.1% | New |
| TENX Tenax Therapeutics, Inc. | 584,412 | $812K | <0.1% | Unchanged |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| CDNA CareDx, Inc. | 1,220,602 | $87.8M |
| ACAD Acadia Pharmaceuticals Inc. | 1,646,399 | $29.0M |
| ARGX argenx SE | 17,707 | $16.7M |
| DYN Dyne Therapeutics, Inc. | 921,598 | $14.8M |
| MNKD MannKind Corporation | 3,458,429 | $13.7M |
| CLDX Celldex Therapeutics, Inc. | 436,646 | $12.2M |
| WAT Waters Corporation | 14,040 | $6.4M |
| COAG Hemab Therapeutics Holdings, Inc. | 160,000 | $6.4M |
| KARD Kardigan, Inc. | 300,000 | $3.8M |